Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants

AIM: The quadrivalent human papillomavirus (4vHPV) vaccine has demonstrated efficacy and immunogenicity and was generally well tolerated in clinical trials conducted in Japan. We report a detailed safety analysis of injection-site reactions in female Japanese 4vHPV clinical trial participants. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Shinya, Shirakawa, Masayoshi, Sugawara, Yoshie, Shuto, Michiko, Sawata, Miyuki, Tanaka, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472855/
https://www.ncbi.nlm.nih.gov/pubmed/32827835
http://dx.doi.org/10.1016/j.pvr.2020.100205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472855/
https://www.ncbi.nlm.nih.gov/pubmed/32827835
http://dx.doi.org/10.1016/j.pvr.2020.100205

Ejemplares similares